| dc.contributor.author | Caplan, Arthur L | |
| dc.date.accessioned | 2021-08-31T10:04:20Z | |
| dc.date.available | 2021-08-31T10:04:20Z | |
| dc.date.issued | 2005 | |
| dc.identifier.citation | Myer, L. et al. (2005). HIV-infected women in ART programmes . Lancet, 365(9460), 655–656. https://doi.org/10.1016/S0140-6736(05)70928-4 | en_US |
| dc.identifier.uri | 1474-547X | |
| dc.identifier.uri | https://doi.org/10.1016/S0140-6736(05)17942-2 | |
| dc.identifier.uri | http://hdl.handle.net/10566/6551 | |
| dc.description.abstract | We are confident that James Shelton
and Anne Peterson (Nov 27, p 1916)1
appreciate the broad reproductive
health needs of women in developing
countries. However, by focusing their
Comment solely on the promotion of
contraceptive use for women on antiretroviral therapy (ART), their discussion overlooks the importance of
supporting reproductive choice among
individuals infected with HIV and
greatly oversimplifies women’s reproductive health-care needs in the context
of ART programmes. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier | en_US |
| dc.subject | HIV | en_US |
| dc.subject | Infected women | en_US |
| dc.subject | ART programmes | en_US |
| dc.subject | Contraceptive use | en_US |
| dc.subject | Women's reproductive | en_US |
| dc.title | HIV-infected women in ART programmes | en_US |
| dc.type | Article | en_US |
